在患有急性冠状动脉综合征的患者中,埃泽提米布的适用性和处方
Dylan Jape1, William B He1, Dion Stub2
1Department of Cardiology, Alfred Health, Melbourne, Vic, Australia.
Heart, lung & circulation
|February 4, 2025
概括
经过急性冠状动脉综合征 (ACS) 后的ezetimibe处方受到澳大利亚制药福利计划标准的限制,尽管患者风险很高,但处方率很低. 合理化标准可以改善高LDL-C的患者的二次预防.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
- 公共卫生 公共卫生
背景情况:
- 埃泽蒂米布是通过降低LDL-C来预防心血管事件的二次预防的关键药物.
- 急性冠状动脉综合征 (ACS) 患者需要有效的LDL-C管理来进行二次预防.
- 澳大利亚制药福利计划 (PBS) 的资格标准影响了ezetimibe的获取.
研究的目的:
- 分析在ACS患者中以泽提米布的适用性和处方模式.
- 为了评估扩大PBS标准对ezetimibe获取的影响.
- 为了确定影响ezetimibe处方后ACS的因素.
主要方法:
- 对曾经服用埃泽提米布的ACS患者的回顾性分析 (2020年5月-2022年7月).
- 根据现有和更严格的LDL-C目标 (1.8和1.4 mmol/L) 评估资格.
- 利用预测建模来识别不太可能通过一线治疗达到目标的患者.
主要成果:
- 只有9.8%的LDL-C>1.8 mmol/L的ACS患者有资格接受ezetimibe;只有16人被处方.
- 立方体禁忌和较高的LDL-C水平预测了ezetimibe的处方.
- 收紧LDL-C目标和预测建模显著增加了潜在的资格.
结论:
- 目前的PBS限制限制了在高风险ACS患者中使用ezetimibe的限制,导致处方率较低.
- 许多ACS患者在不理想的降脂疗法下出院.
- 修订ezetimibe的资格标准可以提高ACS后的早期和有效的二次预防.
相关概念视频
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
522
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
522
01:20Antiepileptic Drugs: Potassium Channel Activators
142
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
142
01:22Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
1.2K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.2K
01:25Antianginal Drugs: Calcium Channel Blockers and Ranolazine
446
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
446
01:17Imaging Studies for Cardiovascular System I:Echocardiography
287
Cardiac imaging studies encompass a wide range of noninvasive and minimally invasive techniques designed to visualize the heart's structure and function in detail. One such technique is echocardiography, which uses high-frequency ultrasound waves to produce detailed images of the heart, known as echocardiograms.
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion,...
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion,...
287
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
375
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
375